Anti-Mouse CD16.2 In Vivo Antibody (9E9) - Ultra-Ultra Low Endotoxin

Anti-Mouse CD16.2 In Vivo Antibody (9E9) - Ultra-Ultra Low Endotoxin

Catalog Number:
A001437679ICH
Mfr. No.:
ICH1194UL
Price:
$832
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Antigen Distribution: FcγRIV is expressed on the cell membrane of splenic and bone marrow dendritic cells, monocytes, and macrophages as well as peripheral blood monocytes, neutrophils, thioglycollate-elicited macrophages, and myeloid cells. FcγRIV is absent from lymphoid populations, T cells, B cells, NK cells, and other granulocytes.
          Specificity: 9E9 activity is primarily directed against mouse CD16.2 / FcγRIV but can also bind and block FcγRIII in vivo.
          Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Armenian Hamster IgG Isotype Control for In Vivo - Low Endotoxin [PIP] (ICH2251)
          Endotoxin: ≤ 0.5 EU/mg as determined by the LAL method
          Aggregation: Aggregation level ≤ 1%

          Please contact us at for specific academic pricing.

          Background

          According to surface plasmon resonance, 9E9 has strong reactivity to FcγRIV as well as low level binding to FcγRII and FcγRIII. In vivo, 9E9 binds and blocks FcγRIII only when 9E9 first binds FcγRIV on the same effector cell, resulting in concurrent inhibition of FcγRIII and FcγRIV. Native 9E9 binds to FcγRII and FcγRIII via the Fc.

          Blocking studies with 9E9 show that FcγRIV is necessary for IgG2a and IgG2b mediated platelet clearance in vivo. Additionally, blocking FcγRIV with 9E9 reduces B-cell depletion. 9E9 also interferes with immune complex binding to FcγRIV and can block FcγRIII on macrophages and neutrophils.

      • Properties
        • Host
          armenian hamster
          Isotype
          IgG
          Reactivity
          mouse
          Clone
          9E9
          Immunogen
          9E9 was produced by immunizing Armenian hamsters with an FcγRIV-IgG1 fusion protein consisting of the extracellular domain of FcγRIV fused to a mouse IgG1 Fc portion (D265A-variant deficient in Fc-receptor binding). Splenic B cells were then fused to a mouse fusion partner, and hybridoma clones were screened for binding to CHO-K1-FcγRIV cells expressing FcγRIV.
          Purification
          >98% by SDS-PAGE and HPLC
          Formulation
          Sterile, preservative-free, solution in PBS. BSA and Azide free.
          Storage
          This antibody is stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
          Molecular Weight
          ≥ 2.0 mg/ml
          Regulatory Status
          Each investigator should determine their own optimal working dilution for specific applications.
          Antigen
          (Gene ID:FcγRIV)

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Blocking; Flow Cytometry

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.